Vincent Picco
Monaco, Monaco
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Integrin β1 signaling at the crossroads of cellular plasticity, the tumor microenvironment, and therapy resistance in medulloblastoma.
Journal: Frontiers in oncology
Published: July 07, 2026
A fistful of iron: ferritin as a vulnerability point of the brain cancers.
Journal: Cell death & disease
Published: July 31, 2025
Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis.
Journal: Current oncology (Toronto, Ont.)
Published: September 20, 2024
Revealing the Ferroptotic Phenotype of Medulloblastoma.
Journal: Journal of visualized experiments : JoVE
Published: April 01, 2024
Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future.
Journal: Cancers
Published: August 21, 2023
Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.
Journal: Cancer research communications
Published: July 12, 2023
Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?
Journal: Pharmaceutics
Published: April 12, 2022
Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells.
Journal: Communications biology
Published: December 08, 2020
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells.
Journal: Communications biology
Published: November 15, 2019
Inhibition of the amino-acid transporter LAT1 demonstrates anti-neoplastic activity in medulloblastoma.
Journal: Journal of cellular and molecular medicine
Published: October 17, 2018
Last Updated: 09/26/2026